İpek Nur Balın Düzgüner

İpek Nur Balın Düzgüner

Auto-generated profile, based on publicly available information

İpek Nur Balın Düzgüner

Assisted Reproductive Technologies and Genetic Center, Memorial Sisli Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
SDSoner Duzguner
Soner Duzguner
FSFulya gokdagli sagir
Fulya gokdagli sagir
IKIbrahim Kale
Ibrahim Kale
IDIpek Nur Balin Duzguner
Ipek Nur Balin Duzguner
Globally and in Turkey, caesarean section (CS) rates have risen steadily over recent decades, reflecting changes in clinical practice, maternal preference,

3 March 2025 in The European Research Journal
Verified
Journal Article
Open access
PDF file
GÖGönül Özer
Gönül Özer
İDİpek Nur Balın Düzgüner
İpek Nur Balın Düzgüner
SÖSevinç Özmen
Sevinç Özmen
SKSemra Kahraman
Semra Kahraman
Objectives: This study aimed to evaluate the effect of varying intervals between human chorionic gonadotropin (hCG) administration and oocyte pickup (OPU) at 34, 35, and 36 hours on in vitro fertilization (IVF) outcomes and embryo development in patients with diminished ovarian reserve (DOR). Methods: This retrospective cohort study utilised the Istanbul Memorial Şişli Hospital, assisted reproductive technology (ART) and Reproductive Genetics Center databases from January 2017 to March 2024. The study included women undergoing ART cycles with DOR, as defined by the Bologna criteria, and follicle-stimulating hormone (FSH) levels exceeding 12 IU/L on day 2 of menstruation. Nine hundred and forty-nine ovarian stimulation cycles were analysed using the gonadotropin-releasing hormone antagonist protocol and triggered by recombinant hCG (r-hCG). The cycles were divided into three groups based on the time interval between r-hCG injection and OPU at 34, 35, and 36 hours. Demographic characteristics, ovarian stimulation parameters, embryological outcomes, and pregnancy results were compared across these groups. Results: The 36-hour OPU group demonstrated the highest fertilization, best embryological outcomes, including the highest blastocyst formation rate (14.95%) compared to the 34-hour (14.23%) and 35-hour (12.43%) groups (P=0.025). The 36-hour group also had the highest proportion of day 5–6 embryo transfers (33.8%, P=0.001). However, there were no significant differences in pregnancy outcomes. Conclusions: In DOR patients, extending the OPU interval to 36 hours with hCG triggering showed higher fertilization rates and better embryo development than 34 and 35 hours. However, it did not affect pregnancy outcomes.